InsiderClue
Stocks · Health care · Pharmaceutical Preparations

OCULAR THERAPEUTIX, INC

OCUL Clue Score42
United States Fiscal year ends December CIK 0001393434 Results filed 3 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

29
Insider
Date
Role
Action
Shares
Price
Amount
Todd Anderman
8 Oct 2026
Chief Legal Officer
Sold on a plan
11,984
$7.29
$87.36K
Jeffrey S. Heier
2 Oct 2026
Chief Scientific Officer
Sold on a plan
10,869
$7.05
$76.63K
Peter Kaiser
2 Oct 2026
Chief Development Officer
Sold on a plan
9,990
$7.05
$70.43K
Donald Notman
31 Aug 2026
Chief Operating Officer
Sell
1,099
$10.24
$11.25K
Pravin Dugel
24 Aug 2026
See Remarks
Sold on a plan
21,649
$10.77
$233.16K
Jeffrey S. Heier
24 Aug 2026
Chief Scientific Officer
Sold on a plan
3,296
$10.78
$35.53K
Sanjay Nayak
24 Aug 2026
Chief Strategy Officer
Sold on a plan
1,897
$10.78
$20.45K
Peter Kaiser
24 Aug 2026
Chief Development Officer
Sold on a plan
3,035
$10.77
$32.69K
Nadia Waheed
3 Jun 2026
Chief Medical Officer
Sold on a plan
14,828
$8.27
$122.63K
Sanjay Nayak
26 May 2026
Chief Strategy Officer
Sold on a plan
1,858
$8.20
$15.24K
Jeffrey S. Heier
26 May 2026
Chief Scientific Officer
Sold on a plan
3,018
$8.20
$24.75K
Peter Kaiser
26 May 2026
Chief Development Officer
Sold on a plan
2,967
$8.20
$24.33K
Pravin Dugel
26 May 2026
See Remarks
Sold on a plan
21,156
$8.20
$173.48K
Sanjay Nayak
23 Feb 2026
Chief Strategy Officer
Sold on a plan
1,759
$8.28
$14.56K
Jeffrey S. Heier
23 Feb 2026
Chief Scientific Officer
Sold on a plan
3,057
$8.28
$25.31K
Peter Kaiser
23 Feb 2026
Chief Development Officer
Sold on a plan
2,810
$8.28
$23.27K
Pravin Dugel
23 Feb 2026
See Remarks
Sold on a plan
20,056
$8.28
$166.06K
Richard L Md Lindstrom
20 Feb 2026
Director
Buy
60,229
$7.66
$461.35K
Nadia Waheed
20 Feb 2026
Chief Medical Officer
Sold on a plan
3,510
$7.74
$27.17K
Nadia Waheed
12 Feb 2026
Chief Medical Officer
Sold on a plan
7,863
$9.04
$71.08K
Pravin Dugel
12 Feb 2026
See Remarks
Sold on a plan
124,882
$9.04
$1.13M
Sanjay Nayak
12 Feb 2026
Chief Strategy Officer
Sold on a plan
10,348
$9.04
$93.55K
Donald Notman
12 Feb 2026
Chief Operating Officer
Sell
11,446
$9.04
$103.47K
Donald Notman
4 Feb 2026
Chief Operating Officer
Sell
6,035
$8.54
$51.54K
Donald Notman
2 Feb 2026
Chief Operating Officer
Sell
5,455
$9.14
$49.86K
Jeffrey S. Heier
24 Nov 2025
Chief Scientific Officer
Sold on a plan
3,469
$12.04
$41.77K
Peter Kaiser
24 Nov 2025
Chief Development Officer
Sold on a plan
3,007
$12.02
$36.14K
Pravin Dugel
24 Nov 2025
See Remarks
Sold on a plan
19,530
$12.04
$235.14K
Sanjay Nayak
24 Nov 2025
Chief Strategy Officer
Sold on a plan
1,878
$12.04
$22.61K

What was left out

Form 4 filings counted 48
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 24
Sales straight out of an exercise 0
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 2,704,361
History held since 31 Jul 2014